A preventive healthcare startup
5 sources · checked 1 time, last 2h ago
Developing: it holds up against its sources so far, and firms up as more reporting lands.
VCCircle explicitly describes the funding amount as undisclosed; no source provides a numeric amount. The sources otherwise agree on the seed round, lead investor, participants, and 15 October 2026 announcement date.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Seed seed funding round | n/a | 2026-10-15 | Inflection Point Ventures | 4 outlets. #91 in Trending |
5 sources · checked 1 time, last 2h ago [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 4 of 5 sources VCCircle explicitly describes the funding amount as undisclosed; no source provides a numeric amount. The sources otherwise agree on the seed round, lead investor, participants, and 15 October 2026 announcement date. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]5 pages read: newspatrolling.com, bwdisrupt.com, localsamosa.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]confirmedchecked against 4 of 5 sources·[ BRANDING ]logo and colour from the homepage·[ AGENT ]company research by the Firecrawl agent | ||||
Vitonnix makes doctor-developed sublingual nutritional sprays for consumers seeking convenient preventive-health supplementation.
Vitonnix is targeting the gap it identifies between swallowing supplements and the body's ability to absorb nutrients, using doctor-developed sublingual sprays built over more than a decade and supported by three completed clinical studies on key formulations. The funding matters because the company says it has sold millions of bottles largely on founder capital, while IPV-led institutional backing is intended to add senior leaders, grow consumers and distribution, and support international expansion including a planned 2026 Boots launch.